Top Five Strategies: Winning the Battle Against Tuberculosis

Multi-Drug Resistant Tuberculosis and the Need for Research

Multi-Drug Resistant Tuberculosis (MDR-TB) is a deadly variant of TB that resists most frontline drugs. The emergence of MDR-TB poses a significant challenge in the fight against TB. Hence, focus should be on enhancing research and innovation to discover newer drugs and treatments that can counter MDR-TB more effectively.

Furthermore, this research should be accompanied by efforts to educate the community about MDR-TB, its risks, and the importance of correct and complete treatment to prevent its spread.